Table 2.
Controls (n = 25) | Donors (n = 23) | p value | |
---|---|---|---|
IVSD (mm) | 10 (9–11) | 10 (8–11) | 0.106 |
LVIDD (mm) | 44 ± 4 | 44 ± 5 | 0.946 |
PWD (mm) | 9 (8–10) | 9 (8–10) | 0.732 |
LVIDS (mm) | 28 ± 3 | 29 ± 4 | 0.470 |
Fractional Shortening (%) | 36 (31–38) | 32 (31–36) | 0.201 |
LVEDVi (ml/m2) | 46 ± 8 | 47 ± 10 | 0.716 |
LVESVi (ml/m2) | 17 (14–19) | 18 (13−22) | 0.713 |
EF (%) | 62 (60–65) | 61 (57–65) | 0.305 |
TAPSE (mm) | 21 ± 3 | 20 ± 3 | 0.168 |
GLS (%) | −19 ± 3 | −19 ± 3 | 0.849 |
LV mass index (g/m2) | 71 (62–88) | 69 (57–76) | 0.307 |
LV geometry n(%) – normal geometry | 17 (68) | 14 (61) | 0.439 |
Concentric remodelling | 6 (24) | 9 (39) | |
Eccentric hypertrophy | 1 (4) | ||
Concentric hypertrophy | 1 (4) | ||
Left atrial volume index (ml/m2) | 19.3 ± 4.3 | 20.5 ± 6.8 | 0.477 |
E/A ratio | 1.2 ± 0.3 | 1.1 ± 0.2 | 0.184 |
E/e’ | 6 (5–8) | 6 (6–7) | 0.655 |
Data are presented as mean ± SD or median (IQR). IVSD – interventricular septal diameter, LVIDD – left ventricular internal diameter diastole, PWD – posterior wall diameter, LVIDS – left ventricular internal diameter systole, LVEDVi – indexed left ventricular end diastolic volume, LVESVi – indexed left ventricular end systolic volume, EF – ejection fraction, TAPSE – tricuspid annular plane systolic excursion, GLS – global longitudinal strain, LV – left ventricular.